NCT03588091 2025-08-22Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast CancerJiangsu HengRui Medicine Co., Ltd.Phase 3 Completed355 enrolled
NCT04957212 2024-07-26Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast CancerCinnagenPhase 3 Completed214 enrolled 16 charts